Formulation and evaluation of taste masked oral disintegrating tablets of lornoxicam
Abstract
Orally disintegrating tablets (ODT) disintegrate quickly with saliva when administered into the oral cavity and taken without water or chewed. ODT are easy to take for children and the elderly, who may experience difficultly in taking ordinary oral preparations such as tablets, capsules, and powders. The ODT threes substantial benefits for the patient (or elder) who cannot swallow (Dysphagia), or who is not permitted water intake due to disease. The reason of the current research was to prepare taste masking oral disintegrating tablets of poorly soluble lornoxicam (LXM) by direct compression technique using Kyron T-114 (cation exchange resin) as a taste masking agent. With in various ratios the Drug-resin of 1:4 was established to present best taste masking. The superdisintegrants used in formulation are croscarmellose sodium and cross povidone. Among these croscarmellose sodium demonstrated superior drug release. The tablets were evaluated for friability, weight variation, wetting time, hardness, disintegration time and uniformity of content. Optimized formulations were evaluated for in vitro dissolution test. Amongst all the formulations F-6 was found to be most successful tablets prepared by this technique had disintegration time of 30sec and % CDR 94.78 within 30min. Hence, this advance can be utilized for taste masking of bitter pharmaceutical ingredients leading to superior patient compliance.
Keywords: Oral disintegration tablets, Lornoxicam, Kyron T-114, Superdisintegrants, Direct Compression.
Keywords:
Oral disintegration tablets, Lornoxicam, Kyron T-114, Superdisintegrants, Direct CompressionDOI
https://doi.org/10.22270/jddt.v11i5.5124References
Bala R, Pawar P, Khanna S, Arora S. Quick dissolving films-a novel approach to drug delivery. Int J Pharm Invest 2003; 3(2):31-34. https://doi.org/10.4103/2230-973X.114897
Sabatini N. Recent patents concerning organoleptic and healthy properties of table olives. Recent Pat Chem Eng 2009; 2(1):37-42. https://doi.org/10.2174/2211334710902010037
Sheth SK, Patel SJ, Shukla JB. Formulation and evaluation of taste masked oral disintegrating tablet of lornoxicam. Int J Pharma Bio Sci 2010; 1(2): 1-9.
Gupta H, Sharma A, Kumar S, Roy SK. E-Tongue: a tool for taste evaluation. Recent Pat Drug Deliv Formul 2010; 4(1):82-89. https://doi.org/10.2174/187221110789957309
Mundada AS, Jain S, Chachda NO, Avari JG. Taste masking approaches-a review: part I. American Pharm Rev 2008; 11(3):94-102.
Gosai AR, Patil SB, Sawant KK. Formulation and evaluation of orodispersible tablets of ondansetron hydrochloride by direct compression using superdisintegrants. Int J Pharm Sci Nanotechnol. 2008; 26(1):106-111. https://doi.org/10.37285/10.37285/ijpsn.2008.1.1.10
Pandey P, Dahiya M. Oral disintegrating tablets: a review. Int J Pharma Res & Rev 2016; 5(1):50-62.
Konapure SA, Chaudhari PS, Oswal RJ, et al. Mouth dissolving tablets an innovative technology. Int J Appl Biol Pharml Tech 2011; 2(1):496-503.
Sreekanth J, Janardhan D, Kumar P T P, Krishna M V. Formulation and evaluation of baclofen orally disintegrating tablets. Int J Pharm Sci Nanotech 2010; 2(4):733-38. https://doi.org/10.37285/ijpsn.2009.2.4.7
Bakde VB, Hedau AS. Design, development and evaluation of orodispersible drug delivery system of taste masked famotidine by newer range of ion-exchange resin. 3495/MUM/2012.
Hamza YE-S, Aburahma MH. Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination. AAPS Pharm Sci Tech. 2009; 10(4):1357. https://doi.org/10.1208/s12249-009-9336-9
Sakore S, Chakraborty B. Formulation and evaluation of enalapril maleate sustained release matrix tablets. Int J Pharm Biomed Res 2013; 4:21-6.
Udayakumar T, Suresh AG, Ubaidulla U. Formulation and evaluation of immediate and sustained release bilayered tablet with glibenclamide and metformin Hcl. Int J Res Dev Pharm Sci 2013; 2:337-43.
Shashidhar P, Vidya Sagar G, Srikanth G. Design and in-vitro evaluation of metformin hydrochloride (SR) and glimepiride (IR) as bilayered tablets. Int J Pharm Chem Sci 2013; 2:780-92.
Sridhar Babu G, Vijay Kumar D, Aishwarya M, Malathy PS, Redya Naik R. Formulation and in vitro characterization of sustained release matrix tablets of metformin Hcl. J Glob Trends Pharm Sci 2014; 5:2085-92.
Saluja V, Garg C. Once-daily sustained-release matrix tablets of metformin hydrochloride based on an enteric polymer and chitosan. J Pharm Educ Res 2013; 4:92-7.
Salsa T, Veiga F, Pina ME. Oral controlled-release dosage forms. i. cellulose ether polymers in hydrophilic matrices Drug Dev Ind Pharm. 1997; 23:929-938. https://doi.org/10.3109/03639049709148697
Liberman HA, Leon L, Schwartz JB. The Theory and Practise of Industrial Pharmacy, Varghese Publishing House, Mumbai, 3rd edition, 1987, 296-303.
Published
Abstract Display: 712 
PDF Downloads: 601 PDF Downloads: 110 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.